By Jonathan Mills in Markets — Apr 18, 2025

Fed Signals Rate Cuts Unlikely as Inflation Risks Persist

Rate cuts off? Inflation sticking? Don't panic. Discover surprisingly simple steps to protect your cash today. Yes, even now.

Market Snapshot

U.S. indices closed mixed ahead of the Good Friday holiday, with notable divergence between large and small caps. The S&P 500 edged up +0.13% to 5,300.29, while the Nasdaq 100 gained +0.45% to 18,320.87. In contrast, the Dow Jones tumbled -1.33% to 39,253.41, dragged down by healthcare components. The Russell 2000 outperformed with a +0.97% rise to 1,881.60.

The VIX fell -9.16% to 29.65 despite the index divergence, breaking historical correlation patterns between volatility and equity performance. The 10-year Treasury yield settled at 4.28%, down 7 basis points week-over-week.

Notable Movers:

Eli Lilly (LLY): +14.3% after obesity drug trial results matched Ozempic efficacy
Luminar Technologies (LAZR): +14.11% on new autonomous vehicle partnership
Insteel Industries (IIIN): +13.81% following major infrastructure contract win
UnitedHealth (UNH): -19% in pre-market trading after guidance cut and Medicare Advantage concerns

Bottom Line: The market displayed extreme bifurcation, particularly in healthcare where LLY's $796B market cap gain offset UNH's $68B loss. This sector-specific volatility, combined with mixed economic data, suggests investors are repositioning ahead of Q1 earnings season while maintaining defensive postures in utilities and consumer staples.

Market Visualizations

Healthcare Sector Bifurcation: LLY vs UNH

Source: NYSE Data (https://www.nyse.com/quote/XNYS:LLY) - Visualization highlighting the dramatic 27-point spread within the healthcare sector, with LLY's $796B market cap gain contrasting sharply with UNH's $68B loss

Pre-Market Pulse

Futures indicated a continuation of the previous day's mixed performance, with defensive positioning evident across major indices:

Dow futures: -1.09% at 39,398, extending losses on UnitedHealth concerns
S&P futures: +0.51% at 5,326.50
Nasdaq futures: +0.32% at 18,427.75

Key pre-market developments driving sentiment:

UnitedHealth (UNH) plunged -19% after cutting guidance and expressing concerns about Medicare Advantage reimbursement rates
D.R. Horton (DHI) dropped -7% following disappointing housing starts data
Taiwan Semiconductor (TSM) gained +2.1% despite tariff concerns after beating Q1 estimates
Economic data releases showed weakness with housing starts at 1.324M (vs 1.42M expected) and the Philly Fed Index at -26.4 (lowest since 2023)

Sector Spotlight

Year-to-date sector performance reveals a dramatic rotation from growth to value, with defensive and commodity-linked sectors leading while technology lags:

Top Performers (YTD):

Energy: +10% - Outperforming despite oil price dips, boosted by Schlumberger's (SLB) $7B shale acquisition
Healthcare: +7% - Extreme bifurcation with LLY's surge offsetting UNH's collapse
Utilities: +6.9% - Benefiting from defensive positioning and rate stabilization

Laggards (YTD):

Technology: -18.5% - Continued pressure from valuation concerns and profit-taking
Materials: -17.1% - Struggling with global growth concerns
Industrials: -12.2% - Weighed down by PMI contraction and supply chain disruptions

The Financial sector has shown resilience with a +3.52% YTD gain despite yield curve flattening, as banks benefit from higher-for-longer interest rates and strong trading revenues.

Bottom Line: The extreme sector rotation signals a fundamental shift in market leadership, with investors prioritizing value, dividends, and defensive characteristics over growth and momentum.

The 27-point spread within healthcare alone demonstrates the market's highly selective approach to valuation, with companies showing strong innovation (like LLY) commanding significant premiums while those facing regulatory headwinds (UNH) experience severe multiple compression.

Economic Beat & Fed Watch

This week's economic data painted a mixed picture of the U.S. economy, with labor market resilience contrasting against manufacturing and housing weakness:

Initial Jobless Claims: 187K (2-month low) - Continuing to signal tight labor market conditions
Housing Starts: -11.4% MoM - Significant miss indicating housing sector challenges
Philadelphia Fed Manufacturing Index: -26.4 vs +10 expected - Dramatic miss suggesting manufacturing contraction

Fed policy expectations remain in flux as March FOMC minutes revealed a 50% probability of a June rate cut. The 10-year Treasury yield settled at 4.28%, down 7 basis points week-over-week, while inflation expectations remained elevated:

2-year Breakeven Inflation Rate: 2.71% (+14bps WoW)
5-year TIPS Spread: 2.43% - Persistently above the Fed's 2% target

Fed Chair Powell noted that potential tariff impacts "may require a prolonged restrictive stance," suggesting the Fed remains cautious about easing too quickly amid persistent inflation pressures.

Bottom Line: The divergence between labor market strength and manufacturing/housing weakness creates a challenging environment for Fed policymakers. With inflation expectations rising and Powell expressing concerns about tariff impacts, the probability of multiple 2024 rate cuts appears to be diminishing, with markets now pricing in fewer than two cuts for the year.

Corporate Central

Eli Lilly (LLY) - Obesity Drug Success

Shares surged +14.3% after reporting its obesity drug trial matched Ozempic's efficacy
The company added nearly $800 billion in market capitalization in a single session
Why it matters: LLY's success solidifies its position in the rapidly growing GLP-1 market, projected to reach $100B annually by 2030

UnitedHealth Group (UNH) - Medicare Advantage Concerns

Shares plummeted -19% in pre-market trading after cutting guidance
The company cited Medicare Advantage reimbursement challenges and higher-than-expected medical costs
Why it matters: UNH's warning signals broader challenges for the managed care industry and potential regulatory headwinds

Taiwan Semiconductor (TSM) - Earnings Beat

Shares gained +2.1% pre-market despite tariff concerns
Q1 results beat estimates on AI chip demand strength
Why it matters: TSM's performance provides a positive readthrough for the semiconductor sector and AI-related demand

Schlumberger (SLB) - Strategic Acquisition

Announced $7 billion shale acquisition to expand North American operations
The deal represents a strategic pivot toward U.S. energy independence
Why it matters: Signals confidence in sustained U.S. energy production growth despite volatile oil prices

Global Market View

International developments continue to influence U.S. market sentiment, with mixed signals from major economies:

China's Q1 GDP surprised to the upside at +5.4% YoY (vs 4.8% expected), suggesting stronger-than-anticipated economic activity in the world's second-largest economy
The European Central Bank held rates steady at 3.75% despite Germany's technical recession, maintaining its cautious stance on inflation
The Japanese Yen strengthened +1.42% against the USD to 151.16 amid rumors of Bank of Japan intervention
Vietnam's dong devaluation has sparked broader emerging market FX concerns, potentially impacting global supply chains

In commodities markets:

Brent crude dipped -0.88% to $87.53 per barrel despite Middle East tensions
Gold edged down -0.15% to $2,341.30 per ounce, pausing its recent rally
Copper gained +1.73% to $4.44 per pound on China's stronger economic data

With approximately 23% of S&P 500 revenue exposed to China, the stronger-than-expected GDP print provides a potential tailwind for U.S. multinationals with significant Asian exposure.

Market Spotlight: Healthcare Sector Bifurcation

Today's market action highlighted an extraordinary divergence within the healthcare sector, creating one of the most dramatic single-day sector bifurcations in recent memory. The contrast between Eli Lilly's meteoric rise and UnitedHealth's collapse represents a microcosm of the broader market's increasingly selective approach to valuation.

Eli Lilly's +14.3% surge came after its obesity drug demonstrated efficacy comparable to Novo Nordisk's Ozempic, solidifying LLY's position in the rapidly expanding GLP-1 market. This single-day move added nearly $800 billion to LLY's market capitalization, representing one of the largest one-day value creations in market history.

Simultaneously, UnitedHealth plummeted -19% in pre-market trading after cutting guidance and expressing concerns about Medicare Advantage reimbursement rates. This $68 billion market cap erosion signals deeper structural challenges for the managed care industry amid evolving healthcare policy.

This stark divergence reflects the market's increasing preference for innovation-driven growth over regulatory-exposed business models. Companies demonstrating breakthrough therapeutic potential are commanding unprecedented premiums, while those facing reimbursement pressures or policy headwinds experience severe multiple compression.

For investors, this bifurcation creates both opportunities and risks. The valuation gap between healthcare innovators and traditional providers has reached extreme levels, potentially setting up mean-reversion trades. However, the fundamental drivers behind this divergence—breakthrough therapies versus regulatory constraints—suggest the gap may persist longer than traditional valuation metrics would indicate.

Analyst Actions

Upgrade by Morgan Stanley to Overweight (from Equal-Weight) with Price Target $825 (from $765) for Eli Lilly (LLY). Rationale: Stronger-than-expected obesity drug efficacy data and expanded market opportunity.
Downgrade by JPMorgan to Neutral (from Overweight) with Price Target $445 (from $570) for UnitedHealth (UNH). Rationale: Medicare Advantage reimbursement challenges and higher medical cost ratio trends.
Upgrade by Goldman Sachs to Buy (from Neutral) with Price Target $180 (from $155) for Taiwan Semiconductor (TSM). Rationale: AI chip demand acceleration and improved margin outlook.
Downgrade by Barclays to Equal-Weight (from Overweight) with Price Target $310 (from $350) for D.R. Horton (DHI). Rationale: Deteriorating housing affordability and weaker-than-expected starts data.

Risk Radar

Healthcare Policy Risk: UnitedHealth's guidance cut signals potential broader challenges for the managed care industry, with Medicare Advantage reimbursement rates becoming a significant headwind that could impact multiple large-cap healthcare names.
Manufacturing Contraction: The Philly Fed Index's dramatic miss (-26.4 vs +10 expected) suggests a more severe manufacturing slowdown than previously anticipated, potentially foreshadowing weaker Q2 GDP growth.
Emerging Market Currency Volatility: Vietnam's dong devaluation could trigger a contagion effect across emerging market currencies, disrupting global supply chains and adding inflationary pressure to consumer goods.

Look Ahead: What to Watch For

Earnings Calendar: Key reports from Netflix (NFLX), Procter & Gamble (PG), and American Express (AXP) will provide insights into consumer spending patterns and subscription growth trends
Economic Data: March Retail Sales (consensus: +0.3% MoM), April Consumer Sentiment preliminary reading (consensus: 79.5), and March Leading Economic Indicators (consensus: -0.3%)
Fed Speakers: Speeches from Fed Governors Waller and Bowman on monetary policy outlook and inflation expectations
International: Bank of Japan policy meeting minutes release and Eurozone PMI flash readings for April
Treasury Auctions: $16 billion in 20-year bonds and $20 billion in 5-year TIPS

As we navigate this period of sector rotation and mixed economic signals, the coming week's earnings reports will be crucial in determining whether the bifurcation we're seeing in healthcare extends to other sectors.

The market appears increasingly selective, rewarding innovation and growth while punishing regulatory exposure and margin pressure.

If you found today's insights valuable, please consider sharing this newsletter with colleagues who might benefit from our analysis. Your feedback helps us continually improve our coverage.